Skip to search formSkip to main contentSkip to account menu

Neprilysin Inhibitors [MoA]

Known as: Neprilysin Inhibitors 
National Institutes of Health

Related topics

Related topics

1 relation
Neprilysin Inhibitor [EPC]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Neprilysin and Natriuretic Peptide Regulation in Heart Failure
Neprilysin is acknowledged as a key player in neurohormonal regulation, a cornerstone of modern drug therapy in chronic heart… 
2016
2016
Neprilysin : Indications , Expectations , and Challenges Neprilisina : indicaciones , expectativas y retos
Neprilysin has become a focus of interest in cardiology, due to the impressive benefits of combining neprilysin inhibition and… 
Highly Cited
2015
Highly Cited
2015
Neprilysin, cardiovascular, and Alzheimer's diseases: the therapeutic split?
Neprilysin (also known as the neutral endopeptidase, EC 3.4.24.11) is a ubiquitous transmembrane and circulating protease with a… 
Review
2015
Review
2015
Combined angiotensin receptor/neprilysin inhibitors: a review of the new paradigm in the management of chronic heart failure.
2011
2011
Comparative efficacy of AHU-377, a potent neprilysin inhibitor, in two rat models of volume-dependent hypertension
Background Progressive hypertension and deteriorating renal function are hallmarks of cardio-renal syndromes. Historically, the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)